Novozymes A/S (NVZMY) Stock Chart & Stock Price History → The only AI company to buy (From Porter & Company) (Ad) Free NVZMY Stock Alerts $59.87 -1.63 (-2.65%) (As of 05/29/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest Novozymes A/S Stock Price Performance5 Day Performance-2.75%1 Month Performance+7.39%3 Month Performance+6.17%6 Month Performance+16.57%Year-To-Date Performance+9.04%1 Year Performance+18.64% Receive NVZMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… NVZMY Stock Chart for Wednesday, May, 29, 2024 NVZMY Chart by TradingView Novozymes A/S Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/29/2024$61.50$59.87-2.65%$60.56$59.737,940 shs$28.04 billion05/28/2024$61.56$61.50-0.10%$61.78$61.285,319 shs$28.80 billion05/27/2024$61.56$61.56$61.90$61.548,300 shs$28.83 billion05/24/2024$61.49$61.56+0.11%$61.90$61.548,306 shs$28.83 billion05/23/2024$62.94$61.49-2.30%$61.97$61.328,806 shs$28.80 billion05/22/2024$62.36$62.94+0.93%$63.24$62.747,397 shs$29.47 billion Get the Latest News and Ratings for NVZMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter. 05/21/2024$63.54$62.36-1.86%$62.47$62.047,765 shs$29.20 billion05/20/2024$63.36$63.54+0.28%$63.89$63.007,850 shs$29.76 billion05/17/2024$62.71$63.36+1.04%$63.68$63.276,275 shs$29.67 billion05/16/2024$62.17$62.71+0.87%$62.96$62.2410,550 shs$29.37 billion05/15/2024$61.07$62.17+1.80%$62.18$61.7810,093 shs$29.11 billion05/14/2024$60.45$61.07+1.03%$61.07$60.647,886 shs$28.60 billion05/13/2024$60.35$60.45+0.17%$60.80$60.4412,823 shs$28.31 billion05/10/2024$60.40$60.35-0.08%$60.82$60.088,089 shs$28.26 billion05/09/2024$60.31$60.40+0.15%$62.40$57.954,495 shs$28.29 billion05/08/2024$59.62$60.31+1.16%$60.48$59.789,518 shs$28.24 billion05/07/2024$58.54$59.62+1.84%$59.91$59.186,864 shs$27.92 billion05/06/2024$59.52$58.54-1.64%$58.65$58.1513,940 shs$27.41 billion05/03/2024$55.89$59.52+6.49%$60.21$58.8410,573 shs$27.87 billion05/02/2024$54.78$55.89+2.02%$56.01$55.537,004 shs$26.17 billion05/01/2024$55.13$54.78-0.63%$55.52$52.964,498 shs$25.65 billion04/30/2024$55.75$55.13-1.11%$56.28$55.136,763 shs$25.82 billion04/29/2024$55.76$55.75-0.02%$56.06$55.7217,417 shs$26.11 billion04/26/2024$55.36$55.76+0.73%$56.08$55.5410,554 shs$26.11 billion04/25/2024$55.66$55.36-0.55%$55.50$54.685,820 shs$25.92 billion04/24/2024$55.75$55.66-0.16%$56.21$55.358,215 shs$26.07 billion04/23/2024$54.96$55.75+1.43%$55.83$55.0816,197 shs$26.11 billion04/22/2024$55.03$54.96-0.13%$55.09$54.7419,961 shs$25.74 billion04/19/2024$54.41$55.03+1.14%$55.49$54.979,034 shs$25.77 billion04/18/2024$54.86$54.41-0.82%$54.73$54.357,883 shs$25.48 billion04/17/2024$54.45$54.86+0.75%$55.03$54.6610,870 shs$25.69 billion04/16/2024$54.45$54.45$55.06$54.455,497 shs$25.50 billion04/15/2024$54.63$54.45-0.33%$55.06$54.455,130 shs$25.50 billion04/12/2024$55.88$54.64-2.22%$55.02$54.545,861 shs$25.59 billion04/11/2024$54.21$55.88+3.08%$55.96$55.3311,815 shs$26.17 billion04/10/2024$55.04$54.21-1.51%$54.55$54.137,585 shs$25.39 billion04/09/2024$56.42$55.04-2.45%$55.41$54.757,393 shs$25.78 billion04/08/2024$56.31$56.42+0.20%$56.68$56.3910,587 shs$26.42 billion04/05/2024$56.31$56.42+0.20%$56.58$55.9510,587 shs$26.37 billion04/04/2024$57.22$56.31-1.59%$56.93$56.0810,042 shs$26.37 billionMissed NVDA? Buy this AI stock NOW (Ad)After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.You can watch it here.04/03/2024$57.09$57.22+0.23%$57.31$56.945,124 shs$26.80 billion04/02/2024$58.29$57.09-2.06%$57.60$56.788,922 shs$26.73 billion04/01/2024$58.86$58.29-0.97%$59.71$58.2410,166 shs$27.30 billion03/29/2024$58.86$58.86$59.20$58.618,435 shs$27.56 billion03/28/2024$58.85$58.86+0.02%$59.20$58.618,435 shs$27.56 billion03/27/2024$59.35$58.85-0.84%$59.01$58.555,666 shs$27.56 billion03/26/2024$58.99$59.35+0.61%$59.45$59.179,152 shs$27.79 billion03/25/2024$59.23$58.99-0.41%$59.17$58.677,624 shs$27.62 billion03/22/2024$58.67$59.23+0.95%$59.47$59.006,283 shs$27.74 billion03/21/2024$61.72$58.67-4.94%$59.04$58.2625,849 shs$27.48 billion03/20/2024$59.85$61.72+3.12%$61.86$60.7711,507 shs$28.90 billion03/19/2024$59.47$59.85+0.64%$60.12$59.159,010 shs$28.03 billion03/18/2024$59.77$59.47-0.50%$59.52$58.757,220 shs$27.85 billion03/15/2024$60.82$59.50-2.17%$60.07$59.367,268 shs$27.86 billion03/14/2024$61.02$60.82-0.33%$61.00$60.6110,230 shs$28.48 billion03/13/2024$61.06$61.02-0.07%$61.20$60.664,145 shs$28.58 billion03/12/2024$60.84$61.06+0.36%$61.06$60.2316,572 shs$28.59 billion03/11/2024$60.95$60.84-0.18%$60.94$60.3313,747 shs$28.49 billion03/08/2024$59.33$60.95+2.73%$61.34$60.7810,728 shs$28.54 billion03/07/2024$58.23$59.33+1.89%$59.35$59.0016,106 shs$27.78 billion03/06/2024$57.71$58.23+0.90%$58.35$57.7310,054 shs$27.27 billion03/05/2024$58.14$57.71-0.74%$57.96$57.5921,976 shs$27.03 billion03/04/2024$57.13$58.14+1.77%$58.22$57.4729,474 shs$27.23 billion03/01/2024$56.39$57.13+1.31%$57.13$56.408,433 shs$26.75 billion02/29/2024$55.76$56.39+1.13%$56.52$56.2023,689 shs$26.41 billion02/28/2024$56.58$55.76-1.45%$55.76$55.4811,102 shs$26.11 billion Related Companies: Gilead Sciences Stock Chart Moderna Stock Chart Biogen Stock Chart BioNTech Stock Chart argenx Stock Chart Neurocrine Biosciences Stock Chart Bio-Techne Stock Chart Qiagen Stock Chart Repligen Stock Chart Vaxcyte Stock Chart Receive NVZMY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:NVZMY) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTruth about Trump you’ve never heardPorter & CompanyBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novozymes A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.